IBM (IBM) shares are climbing Tuesday as buyers pile into large-cap tech stocks and the broader market stays in risk-on mode. The Nasdaq is up 0.32%, and the S&P 500 has gained 0.11%. But the real story isn't just today's price action—it's the company's massive bet on quantum computing.

IBM Commits $10 Billion to Quantum Computing

On Tuesday, IBM said it will invest more than $10 billion over the next five years to accelerate its quantum computing roadmap. The goal: build the world's first large-scale, fault-tolerant quantum computer by 2029. The money will go toward R&D, manufacturing expansion, capital expenditures, ecosystem partnerships, and acquisitions. IBM says the investment is designed to strengthen U.S. leadership in quantum technology.

“The quantum era is no longer ahead of us, it has started. Our clients, partners and users around the world are tapping into IBM quantum computers to do work that was impossible a few years ago,” said Chairman and CEO Arvind Krishna. “The pace of discovery with quantum computers is accelerating rapidly and this investment powers our ability to deliver the next generation of quantum hardware, software, and manufacturing.”

IBM already operates more than 90 quantum systems globally, including cloud-based and on-site deployments in the U.S., Germany, Japan, South Korea, Spain, Canada, and India. Its planned IBM Quantum Starling system, expected in 2029, will be capable of executing 20,000 times more operations than current systems.

Quantum Adoption Is Growing

Since 2017, IBM has signed over $1.1 billion in quantum-related contracts and built a network of more than 340 organizations using its quantum platforms. The company also recently announced plans to launch Anderon, described as the world's first pure-play quantum wafer foundry, backed by a $1 billion cash contribution from IBM. IBM expects partners using its systems to demonstrate quantum advantage in 2026 as real-world applications expand.

Technical Analysis: Overbought and Extended

IBM's stock is trading well above its moving averages—34.2% above its 20-day SMA, 34% above its 50-day, 25.4% above its 100-day, and 19% above its 200-day. That kind of extension often invites profit-taking or at least a cooling-off period. The longer-term picture still shows a bearish moving-average structure, with a death cross that formed in March (50-day below 200-day) and the 20-day still below the 50-day.

Momentum is the bigger story right now: the Relative Strength Index (RSI) is at 83.92, firmly in overbought territory. That signals the rally has become stretched and could be vulnerable to sharp pullbacks, even if the primary trend remains intact. Traders will be watching whether any dips remain shallow (bullish) or start breaking prior support levels (a sign the overbought condition is resolving through price, not time).

• Key Resistance: $325.00 — a nearby round-number area just above current levels where upside attempts could stall.
• Key Support: $296.00 — a prior demand zone that would be a key “line in the sand” if the stock finally pulls back.

Earnings Preview and Analyst Outlook

IBM is scheduled to report its next quarterly results on July 22, 2026 (estimated). Analysts expect earnings per share of $3.02, up from $2.80 a year ago, and revenue of $17.86 billion, up from $16.98 billion. The stock trades at a price-to-earnings ratio of 28.4x, a premium to many peers.

The analyst consensus is a Buy, with an average price target of $291.54. Recent analyst actions include:

• Barclays: Initiated with Overweight and a $350.00 target (June 1)
• Wedbush: Outperform, maintaining a $320.00 target (May 29)
• RBC Capital: Outperform, lowering its target to $300.00 (May 6)

Notably, the average analyst target of $291.54 is below the current stock price of around $323, suggesting that the stock has already run ahead of many analysts' expectations.

Funds Most Invested in IBM

IBM is a significant holding in several dividend-focused ETFs, which means flows into or out of these funds can move the stock:

• First Trust NASDAQ Technology Dividend Index Fund (TDIV): 6.97% weight
• FT Vest Technology Dividend Target Income ETF (TDVI): 8.42% weight
• Invesco Dow Jones Industrial Average Dividend ETF (DJD): 5.09% weight

Because IBM carries such heavy weight in these funds, any significant inflows or outflows will likely force automatic buying or selling of the stock.

Price Action: IBM shares were up 0.81% at $323.02 at the time of publication Tuesday.